VERACYTE, INC.·4

Jan 12, 5:27 PM ET

Anderson Bonnie H 4

4 · VERACYTE, INC. · Filed Jan 12, 2023

Insider Transaction Report

Form 4
Period: 2023-01-11
Anderson Bonnie H
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-11$14.34/sh+63,247$906,962126,208 total
  • Sale

    Common Stock

    2023-01-11$25.13/sh63,247$1,589,19562,961 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-01-1163,24726,753 total
    Exercise: $14.34Exp: 2024-02-19Common Stock (63,247 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    123,514
Footnotes (3)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]The option is fully vested.

Documents

1 file
  • 4
    wf-form4_167356241552627.xmlPrimary

    FORM 4